Soros Fund Management’s Bristol-Myers Squibb BMY Stock Holding History

Soros Fund Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-10	Closed	–	–	156
2019 Q1	$0	Buy	+10	New	+$498	﹤0.01%	172
2015 Q4	–	Sell	-5,000	Closed	-$296K	–	253
2015 Q3	$296K	Buy	+5,000	New	+$317K	﹤0.01%	216
2014 Q1	–	Sell	-100,000	Closed	-$5.32M	–	315
2013 Q4	$5.32M	Hold	100,000	–	–	0.05%	180
2013 Q3	$4.63M	Hold	100,000	–	–	0.05%	159
2013 Q2	$4.47M	Buy	+100,000	New	+$4.34M	0.05%	157

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Soros Fund Management's BMY Position: Q2 2019 in Review

Soros Fund Management sold out of Bristol-Myers Squibb (BMY) in Q2 2019, closing a stake of 10 shares.

Soros Fund Management first reported a position in BMY in Q2 2013 and held it in 5 quarters. The position peaked at $5.32M in Q4 2013. 1,777 funds tracked by Wall St. Rank hold BMY as of Q2 2019.

Soros Fund Management reported no remaining Bristol-Myers Squibb position as of Q2 2019 after selling out during the quarter.
Soros Fund Management sold 10 Bristol-Myers Squibb shares in Q2 2019.
Soros Fund Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 5 quarters.
Soros Fund Management's Bristol-Myers Squibb position peaked at $5.32M in Q4 2013.
1,777 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2019.

Based on Soros Fund Management's 13F filing for Q2 2019, filed 14 Aug 2019.